Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
GE HealthCare reported its second quarter 2024 financial results, revealing a significant revenue miss that has led to a decline in its stock price. The company announced a revised annual organic revenue growth forecast, lowering it to a range of 1% to 2%, down from approximately 4%. This adjustment is attributed to anticipated slowdowns in sales, particularly in China. Following these announcements, GE HealthCare's stock experienced a notable drop, reflecting investor concerns over the company's financial performance and outlook.
GE Healthcare stock tumbles as revenue falls short of expectations
GE HealthCare’s Stock Is Dropping After Earnings Beat. Here’s Why. https://t.co/HOv0A9vlmA
🔵 GE HEALTHCARE CUTS 2024 ORGANIC SALES GROWTH FORECAST, SHARES FALL Full Story → https://t.co/wUVBVF8KEG GE Healthcare On Wednesday cut its annual organic revenue growth forecast to a range of 1% to 2% from about 4%, as it expects a slowdown in China sales. https://t.co/4DG6prUmLD